Success Metrics

Completion Rate
0%(0/1)
Active Trials
4(80%)
Terminated
1(20%)

Phase Distribution

Ph not_applicable
3
60%
Ph phase_3
2
40%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution5 total trials
Phase 3Large-scale testing
2(40.0%)
N/ANon-phased studies
3(60.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

4

trials recruiting

Total Trials

5

all time

Status Distribution
Active(4)
Terminated(1)

Detailed Status

Recruiting4
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
4
Success Rate
0.0%
Most Advanced
Phase 3

Trials by Phase

Phase 32 (40.0%)
N/A3 (60.0%)

Trials by Status

terminated120%
recruiting480%

Recent Activity

4 active trials
Showing 5 of 5
recruitingphase_3

Chemotherapy De-escalation in HR +, HER2-, Intermediate-risk Early Breast Cancer Treated With Adjuvant Ribociclib

NCT07237256
recruitingphase_3

Personalizing the Use of Pembrolizumab for Patients Who Have a Strong Response in Early Triple Negative Breast Cancer

NCT06606730
recruitingnot_applicable

De-escalation of Radiation Dose in HPV-associated OPC Utilising FMISO PET (DE-RADIATE)

NCT06307015
recruitingnot_applicable

The T-REX Trial: Tailored Regional External Beam Radiotherapy in Clinically Node-negative Breast Cancer Patients With 1-2 Sentinel Node Macrometastases.

NCT05634889
terminatednot_applicable

A B-D-Glucan Driven Antifungal Stewardship Approach for Invasive Candidiasis

NCT03090334

Clinical Trials (5)

Showing 5 of 5 trials
NCT07237256Phase 3

Chemotherapy De-escalation in HR +, HER2-, Intermediate-risk Early Breast Cancer Treated With Adjuvant Ribociclib

Recruiting
NCT06606730Phase 3

Personalizing the Use of Pembrolizumab for Patients Who Have a Strong Response in Early Triple Negative Breast Cancer

Recruiting
NCT06307015Not Applicable

De-escalation of Radiation Dose in HPV-associated OPC Utilising FMISO PET (DE-RADIATE)

Recruiting
NCT05634889Not Applicable

The T-REX Trial: Tailored Regional External Beam Radiotherapy in Clinically Node-negative Breast Cancer Patients With 1-2 Sentinel Node Macrometastases.

Recruiting
NCT03090334Not Applicable

A B-D-Glucan Driven Antifungal Stewardship Approach for Invasive Candidiasis

Terminated

All 5 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
5